ANROVSBTAI• 3 Months (Normalized)
ANRO vs BTAI (Alto Neuroscience Inc. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $27.5
+%
Alto Neuroscience Inc.
Normalized Baseline0.00%
BTAI Performance $0.04
-97.44%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ANRO LEADS
+97.44 pts
ANRO outperforming by 97.44 percentage points
ANROBTAI
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO BTAI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(59 dates)
| Date | ANRO Price | ANRO Gain (%) | BTAI Price | BTAI Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 24, 2026 | $- | $0.04 | -97.44% | - | |
| Sep 23, 2026 | $27.50 | +10.98% | $0.05 | -96.74% | +107.72% |
| Sep 22, 2026 | $30.78 | +24.21% | $0.04 | -96.77% | +120.98% |
| Sep 21, 2026 | $30.63 | +23.61% | $0.06 | -95.54% | +119.15% |
| Sep 18, 2026 | $30.27 | +22.15% | $0.06 | -95.80% | +117.95% |
| Sep 17, 2026 | $30.98 | +25.02% | $0.08 | -94.56% | +119.58% |
| Sep 16, 2026 | $30.00 | +21.07% | $0.07 | -95.15% | +116.22% |
| Sep 15, 2026 | $30.25 | +22.07% | $0.04 | -96.76% | +118.83% |
| Sep 14, 2026 | $31.68 | +27.85% | $0.05 | -96.73% | +124.58% |
| Sep 11, 2026 | $32.00 | +29.14% | $0.05 | -96.30% | +125.44% |
| Sep 10, 2026 | $31.68 | +27.85% | $0.05 | -96.38% | +124.23% |
| Sep 09, 2026 | $34.07 | +37.49% | $0.05 | -96.59% | +134.08% |
| Sep 08, 2026 | $35.81 | +44.51% | $0.04 | -96.88% | +141.39% |
| Sep 04, 2026 | $35.55 | +43.46% | $0.07 | -94.64% | +138.10% |
| Sep 03, 2026 | $36.40 | +46.89% | $0.12 | -91.45% | +138.34% |
Page 1 of 4